Necitumumab Combined with Gemcitabine and Cisplatin Closer to Becoming First-Line Therapy in Squamous NSCLC
Lung Cancer, News
Recently, the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC), whose main function is to evaluate both safety and effectiveness of human drugs (already in the market ... Read more